BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14737040)

  • 1. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
    Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus.
    Rahimi M; Hasanvand A; Rahimi Z; Vaisi-Raygani A; Mozafari H; Rezaei M; Zargooshi J; Najafi F; Shakiba E
    Clin Biochem; 2010 Nov; 43(16-17):1333-9. PubMed ID: 20800057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
    El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients.
    Shcherbak NS; Shutskaya ZV; Sheidina AM; Larionova VI; Schwartz EI
    Mol Genet Metab; 1999 Nov; 68(3):375-8. PubMed ID: 10562465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
    Sun J; Xu Y; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients.
    Tomić NG; Marusić S; Bozikov V; Kusec R; Bacić-Vrca V; Tadić M
    Coll Antropol; 2013 Sep; 37(3):789-93. PubMed ID: 24308218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between methylenetrahydrofolate reductase gene and ischemic stroke].
    Li CM; Zhang C; Lu XL; Feng HY; Su QX; Zeng Y; Zhang HL; Qiu SL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):264-7. PubMed ID: 16700986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C677T and A1298C mutation of the methylenetetrahydrofolate reductase gene in unexplained recurrent spontaneous abortion].
    Wang XP; Lin QD; Ma ZW; Zhao AM
    Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):238-41. PubMed ID: 15130349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition for development of nephropathy in type 2 diabetes mellitus.
    Kumar R; Sharma RK; Agarwal S
    Biochem Genet; 2013 Dec; 51(11-12):865-75. PubMed ID: 23846111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
    Tylicki L; Födinger M; Puttinger H; Rutkowski P; Strozecki P; Tyszko S; Rutkowski B; Hörl WH
    Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.